MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: *Investment Round
Venture Capital: Series F
Antisense Pharma
Attachments
Antisense Pharma
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
*Industry: Germany
Venture Capital: Series F
Children
Biopharmaceutical company focused on antisense gene silencing for pancreatic cancer, malignant melanoma and colorectal cancer:Closed a $11M Series F financing.
Participants include MIG Fonds and Global Asset Fund.
Series F $11M by OnBioVC (2012)